Registro:

Referencias:

• Blombäck, B., Fibrinogen and fibrin-proteins with complex roles in haemostasis and thrombosis (1996) Thromb Res, 83 (1), pp. 1-75
• Moen, J.L., Lord, S.T., Afibrinogenemias and dysfibrinogenemias (2006) Haemostasis and Thrombosis. Basic Principles and Clinical Practice, pp. 939-952. , Colman RW, Marder VJ, Clowes AW, George JN, Goldhaber SZ, editors. 5th ed, Philadelphia: Lippincott Williams & Wilkins
• Moerloose, P., Neerman-Arbez, M., Congenital fibrinogen disorders (2009) Semin Throm Hemost, 35 (4), pp. 356-366
• Asselta, R., Duga, S., Tenchini, M.L., The molecular basis of quantitative fibrinogen disorders (2006) J Thromb Haemost, 4 (10), pp. 2115-2129
• Peyvandi, F., Epidemiology and treatment of congenital fibrinogen deficiency (2012) Thromb Res, 130, pp. 7-11
• Hanss, M., Biot, F., A database for human fibrinogen variants (2001) Ann N y Acad Sci, 936, pp. 89-90
• Hill, M., Dolan, G., Diagnosis, clinical features and molecular assessment of the dysfibrinogenaemias (2008) Haemophilia, 14, pp. 889-897
• Krammer, B., Anders, O., Nagel, H.R., Burstein, C., Steiner, M., Screening of dysfibrinogenaemia using the fibrinogen function versus antigen concentration ratio (1994) Thromb Res, 76 (6), pp. 577-579
• Moerloose, P., Casini, A., Neerman-Arbez, M., Congenital fibrinogen disorders: An update (2013) Semin Thromb Hemost, 39, pp. 585-595
• Casini, A., Blondon, M., Lebreton, A., Koegel, J., Tintillier, V., De Maistre, E., Natural history of patients with congenital dysfibrinogenemia (2015) Blood, 125 (3), pp. 553-561
• Haverkate, F., Samama, M., Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen (1995) Thromb Haemost, 73 (1), pp. 151-161
• Shapiro, S.E., Phillips, E., Manning, R.A., Morse, C.V., Murden, S.L., Laffan, M.A., Clinical phenotype, laboratory features and genotype of 35 patients with heritable dysfibrinogenaemia (2013) Br J Haematol, 160 (2), pp. 220-227
• Casini, A., De Moerloose, P., Neerman-Arbez, M., Clinical features and management of congenital fibrinogen deficiencies (2016) Semin Thromb Hemost
• Lauricella, A.M., Castañon, M.M., Kordich, L.C., Quintana, I.L., Alterations of fibrin network structure mediated by dermatan sulfate (2013) J Thromb Thrombolysis, 35 (2), pp. 257-263
• Lauricella, A.M., Quintana, I., Castañon, M.M., Sassetti, B., Kordich, L., Influence of homocysteine on fibrin network lysis (2006) Blood Coagul Fibrinolysis, 17, pp. 181-186
• Lahiri, D.K., Nurnberger, J.I., A rapid non-enzimatic method for the preparation of HMW DNA from blood for RFLP studies (1991) Nucleic Acids Research, 19, p. 5444
• Ivaskevicius, V., Jusciute, E., Steffens, M., Geisen, C., Hanfland, P., Wienker, T., Gamma Ala82Gly represents a common fibrinogen gamma-chain variant in Caucasians (2005) Blood Coagul Fibrinolysis, 16 (3), pp. 205-208
• Weisel, J.W., Litvinov, R.I., Mechanisms of fibrin polymerization and clinical implications (2013) Blood, 121 (10), pp. 1712-1719
• Wolberg, A.S., Gabriel, D.A., Hoffman, M., Analysing fibrin clot structure using a microplate reader (2002) Blood Coagul Fibrinol, 13 (6), pp. 533-539
• Weisel, J.W., Litvinov, R.I., The biochemical and physical process of fibrinolysis and effects of clots structure and stability on the lysis rate (2008) Cardiovasc Hematol Agents Med Chem, 6 (3), pp. 161-180
• Rose, T., Di Cera, E., Three-dimensional modeling of thrombin-fibrinogen interaction (2002) J Biol Chem, 277 (21), pp. 18875-18880
• Stubbs, M.T., Oschkinat, H., Mayr, I., Huber, R., Angliker, H., Stone, S.T., The interaction of thrombin with fibrinogen (1992) Eur J Biochem, 206 (1), pp. 187-195
• Kaczmarck, E., McDonagh, J., Thrombin binding to the Aα-, Bβ-, and γ-chains of fibrinogen and to their remnants contained in fragment e (1988) J Biolog Chemist, 263 (27), pp. 13896-13900
• Niwa, B.Z., Yaginuma, A., Nakanishi, M., Wada, Y., Sugo, T., Fibrinogen Mitaka II: A heredaty dysfibrinogen with defective thrombin binding caused by an Aα Glu-11 to Gly substitution (1993) Blood, 82 (12), pp. 3658-3663
• Ni, F., Konishi, Y., Bullock, L.D., Rivetna, M.N., Scheraga, H.A., High-resolution NMR studies of fibrinogen-like peptides in solution: Structural basis for the bleeding disorder caused by a single mutation of Gly(12) to Val(12) in the A alpha chain of human fibrinogen Rouen (1989) Biochemistry, 28 (7), pp. 3106-3119
• Kotlín, R., Zichová, K., Suttnar, J., Reicheltová, Z., Salaj, P., Hrachovinová, I., Congenital dysfibrinogenemia Aα Gly13Glu associated with bleeding during pregnancy (2011) Thromb Res, 127 (3), pp. 277-278

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------